Kairos Pharma, LTD. (KAPA) Form 10-K Annual Reports
Kairos Pharma, LTD. (KAPA) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KAPA
CIK: 1962011
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerCorey Fischer
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001493152-26-045844 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001493152-26-042569 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | 8-K | 0001493152-26-039695 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001493152-26-037355 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-16 | 8-K | 0001493152-26-034185 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | 8-K | 0001493152-26-033289 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-29 | 8-K | 0001493152-26-031328 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | 8-K | 0001493152-26-027200 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-26 | — | DEFA14A | 0001493152-26-025287 | View SEC Doc Filr Page |
| ARS | 2026-05-22 | 2025-12-31 | ARS | 0001493152-26-025021 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-22 | 2026-05-22 | DEF 14A | 0001493152-26-025020 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001493152-26-024082 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001493152-26-022796 | View SEC Doc Filr Page |
| PRE 14A | 2026-05-11 | 2026-05-11 | PRE 14A | 0001493152-26-022194 | View SEC Doc Filr Page |
| 424B3 | 2026-04-01 | — | 424B3 | 0001493152-26-014692 | View SEC Doc Filr Page |
| 424B3 | 2026-04-01 | — | 424B3 | 0001493152-26-014691 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001493152-26-014159 | View SEC Doc Filr Page |
| 8-K | 2026-03-02 | 2026-03-02 | 8-K | 0001493152-26-008435 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | 8-K | 0001493152-26-008116 | View SEC Doc Filr Page |
| EFFECT | 2026-01-23 | — | EFFECT Filing | 9999999995-26-000284 | View SEC Doc Filr Page |
| CORRESP | 2026-01-21 | — | CORRESP Filing | 0001493152-26-002996 | View SEC Doc Filr Page |
| UPLOAD | 2026-01-15 | — | UPLOAD Filing | 0000000000-26-000555 | View SEC Doc Filr Page |
| S-3 | 2026-01-13 | — | S-3 | 0001493152-26-001909 | View SEC Doc Filr Page |
| 4 | 2025-12-30 | 2025-10-08 | 4 | 0001493152-25-029601 | View SEC Doc Filr Page |
| 4 | 2025-12-23 | 2025-09-16 | 4 | 0001493152-25-028895 | View SEC Doc Filr Page |